Comparison of two mechanical intraosseous infusion devices: A pilot, randomized crossover trial

Shavit, Itai; Hoffmann, Yoav; Galbraith, Roger; Waisman, Yehezkel

doi:10.1016/j.resuscitation.2009.05.026

Cited by 67 publications

(40 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The proximal tibia is already exposed during TKA, and modern intraosseous cannulation system kits offer rapid access [25]. The average time for cannulation and injection in this study was under 2 minutes, and thus a minimal difference in overall tourniquet time was observed between the two groups.…”

Section: Discussionmentioning

confidence: 73%

Higher Cefazolin Concentrations with Intraosseous Regional Prophylaxis in TKA

Young

Zhang

Freeman

et al. 2013

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 73%

Higher Cefazolin Concentrations with Intraosseous Regional Prophylaxis in TKA

Young

Zhang

Freeman

et al. 2013

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

“…with the BIG device) and successful first attempt (EZ-IO: 90%, BIG: 80%) [4]. Other studies report similar success rates (96%, 96.5%, 97%) with the EZ-IO [5,9,12]. Success rates of central venous canulation and IO access were compared in 10 trauma patients on whom peripheral vascular access could not be achieved after three attempts for a maximum of two minutes; first attempt success rate was 90% for IO access and 60% for central venous access.…”

Section: Discussionmentioning

confidence: 92%

The Efficacy of Intraosseous Blood and Ringer Lactate in a Rabbit Model of Hemorrhagic Hypovolemia

Korkmaz¹

2013

CMR

View full text Add to dashboard Cite

Purpose: In this study, flow rates of intraosseously (IO) or intravenously (IV) administered fluids (blood orRinger lactate) and their effects on vital signs were examined in a rabbit model of hypovolemia. Methods: Underanesthesia, 20 mL of blood was removed from each of the 36 New Zealand-type rabbits. Ten minutes later, each group of nine rabbits received one of four fluids by gravity flow from a height of 100 cm: blood via IO, Ringer Laktat (RL) via IO, blood via IV, or RL via IV. IO fluids were given in the proximal tibia through a 15 g needle placed with an EZ-IO instrument; IV fluids were given through a 22g catheter in the femoral vein. Vital signs were monitored for four hours after the infusion ended. Results: Flow rates were blood IO 2.6 mL/min, RL IO 3.4 mL/min, blood IV 3.2 mL/min, and RL IV 11.8 mL/min. Ten minutes after fluid administration ended, in the RL via IO group, heart rate was significantly slower than preinfusion; in the blood via IO group, body temperature was significantly lower than preinfusion, and in the blood via IO group, StO2 saturation was higher than preinfusion. Postinfusion respiratory rates within groups were not significantly different than preinfusion rates. Vital sign changes between groups were not significantly different. Conclusion: Fluids given by gravity feed through an IO needle were effective in treating hypovolemia in this rabbit model, but the flow of RL and blood were significantly slower through the 15g IO needle than the 22g IV catheter.

show abstract

“…En el caso que no se pueda conseguir un acceso intravenoso en los primeros 2 min de reanimación, se debe intentar conseguir una vía intraósea (IO) para la administración de los fármacos. La disponibilidad cada vez mayor de estos dispositivos ha aumentado la facilidad de realizar esta técnica 25,26 . Las dosis por vía IO son las mismas que por vía intravenosa.…”

Section: Algoritmo De Soporte Vital Avanzado Universal «Simplificado»unclassified

Novedades en soporte vital avanzado

et al. 2011

View full text Add to dashboard Cite

Recibido el 6 de marzo de 2011; aceptado el 11 de marzo de 2011 PALABRAS CLAVEParada cardiaca; Resucitación; Soporte vital avanzado; Posresucitación; Pronóstico; Donación de órganos Resumen Se presentan a continuación algunas de las novedades más importantes en soporte vital avanzado que incorporan las nuevas recomendaciones internacionales en resucitación de 2010. Se destacan los aspectos relacionados con la prevención y detección precoz de la parada cardiaca intrahospitalaria, la resucitación en el hospital, el nuevo algoritmo de soporte vital avanzado, las técnicas y dispositivos de resucitación cardiopulmonar, los cuidados posresucitación, la valoración del pronóstico de los pacientes que sobreviven inicialmente a la parada y aspectos específicos relativos a la donación de órganos a corazón parado y la creación de centros de referencia de parada cardiaca. © 2011 Elsevier España, S.L. y SEMICYUC. Todos los derechos reservados. KEYWORDS Novelties in advanced life supportSummary We present some of the most important developments in advanced life support incorporating the new international recommendations for resuscitation 2010. The study highlights aspects related to prevention and early detection of in-hospital cardiac arrest, resuscitation in the hospital, the new advanced life support algorithm, the techniques and devices for cardiopulmonary resuscitation, post-resuscitation care, assessment of the prognosis of patients who survive initially, and specific aspects of non-beating heart organ donation and the creation of cardiac arrest referral centers.

show abstract

Comparison of two mechanical intraosseous infusion devices: A pilot, randomized crossover trial

Cited by 67 publications

References 17 publications

Higher Cefazolin Concentrations with Intraosseous Regional Prophylaxis in TKA

Higher Cefazolin Concentrations with Intraosseous Regional Prophylaxis in TKA

The Efficacy of Intraosseous Blood and Ringer Lactate in a Rabbit Model of Hemorrhagic Hypovolemia

Novedades en soporte vital avanzado

Contact Info

Product

Resources

About